Want to create an interactive transcript for this episode?
Podcast: Relentless Health Value
Episode: EP396: How to Answer This Question: Will Humira® Biosimilars Reduce Drug Spend? With Anna Hyde
Description: There are two facets of the Humira biosimilar market and launch that Anna Hyde, my guest in this healthcare podcast, talks about. One is market dynamics. The second is provider and patient confidence. These two concepts are tangled up together and cannot be separated. But let me back up a sec and explain, although Anna Hyde covers this really well and offers context in the interview that follows. So, first facet: market dynamics. This means fostering competition so the price of something goes down. That is the basis of capitalism. After all, you need competition...